Skip to content

Antoine Pharma

Active
Private limited companyfounded 20197 years activeFernand Cocqplein 26, 1050 Elsene, BelgiumKBO/BCE: BE 0732.705.039
Summary

Antoine Pharma has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,552 and a net result of €106,892. Equity is growing by ~33.4% per year across the filed fiscal years. Its solvency ranks better than 15% of 4,922 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
Size
€1.5mtotal assets 2025
Equity
€60,552
Profit
€106,892
Financial health
65 Healthy Checked score 2025
Bankruptcy probability, 12 months
1.0%
Structure
Holdings
1
Accounts 63 days early0 of 3 deeds read
Why 65- Equity €60,552 (4.2% of total assets)- Sector Retail trade (NACE 47)- No establishment unit in the KBO+ Size: total assets €1.5mShow the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 31% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 29-21
equity 4.2% of total assets
Liquidity 30-14
short-term debt 62.3% · cash 10.4%
Profitability 78+24
return on assets 7.3%
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,155 companies)
Last 24 months 11-2024: 0.6% 12-2024: 0.6%● unchanged vs 11-2024 01-2025: 0.6%● unchanged vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.6%● unchanged vs 03-2025 05-2025: 0.7%▲ +0.1 percentage points vs 04-2025 06-2025: 0.9%▲ +0.2 percentage points vs 05-2025 07-2025: 0.5%▼ -0.4 percentage points vs 06-2025 08-2025: 0.5%● unchanged vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025lowest value 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.5%● unchanged vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.6%▲ +0.1 percentage points vs 04-2026 06-2026: 1.0%▲ +0.4 percentage points vs 05-2026 07-2026: 1.0%● unchanged vs 06-2026highest value 08-2026: 1.0%● unchanged vs 07-2026highest value 09-2026: 1.0%● unchanged vs 08-2026highest value 10-2026: 1.0%● unchanged vs 09-2026highest value
Credit up to €3,500 at 30 days acceptable
Liquidity short (current ratio 0.18 against 0.25 in 2024; short-term debt: 62.3% and cash: 10.4% of total assets), and 95.8% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 22% on solvency, 27% on liquidity, 67% on profitability and 7% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €1.5m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €60,552 (4.2% of total assets)
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
KBO
raises risk · No establishment unit in the KBO
KBO · seat and establishments
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 4922 sector peers (2025).
NBB · sector comparison
Position among 4922 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
63 days early
2024
42 days early
2023
36 days early
2022
61 days early
2021
52 days early
2020
66 days early
2019
65 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 55 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 9 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Annual accounts filedfiscal year 2024 · full…
  3. Annual accounts filedfiscal year 2023 · full…

Key points

  • Caution: Equity fell in 2025from €353,659 to €60,552 ▼ 82.9% View
  • Caution: Among the weakest 15% on solvencysector median 36.2% · 4,922 companies 4.2% View
  • Positive: Always filed on timeaccounts within the deadline every year 7 years View
  • Positive: 7 profitable years in a rowprofit 2025: €106,892 7 years View

By topic

Financials

Fiscal year
2025
Total assets
€1.5m
Profit
€106,892
Solvency
4.2%
Total assets▲ 4.2%
Net result
20192025
Go to Financials

Timeline

Events
10
Since
2020
Next accounts
by 31-07-2027
  1. 31-12-2023Highest result since 2019
  2. 31-05-2023Annual accounts filed
  3. 31-12-2022Equity above €200,000
Go to Timeline

Company details

Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
20-08-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.